Barnes v. United States

2025 CIT 65
United States Court of International Trade·Decided May 23, 2025·No. 25-00043·Published

Opinion

Slip-Op. 25-65

UNITED STATES COURT OF INTERNATIONAL TRADE

GARY L. BARNES,

Plaintiff, Before: Jennifer Choe-Groves, Judge v.

Court No. 25-00043

UNITED STATES,

Defendant.

OPINION AND ORDER

[Granting Defendant’s motion to dismiss without prejudice.]

Date: May 23, 2025

Gary L. Barnes, of Green Bay WI, proceeding pro se.

Justin R. Miller, Attorney-in-Charge, Eric E. Laufgraben, Senior Trial Counsel, and Luke Mathers, Trial Attorney, Commercial Litigation Branch, Civil Division, U.S. Department of Justice, of Washington, D.C., for Defendant United States. With them on the brief were Yaakov M. Roth, Acting Assistant Attorney General, Patricia M. McCarthy, Director, and Claudia Burke, Deputy Director.

Choe-Groves, Judge: Plaintiff Gary L. Barnes (“Plaintiff” or “Barnes”) filed this action as a private citizen challenging the constitutionality of tariffs announced and imposed by the President of the United States, Donald J. Trump. Compl., ECF No. 3. Before the Court is the Motion to Dismiss (“Motion”) filed by Defendant United States (“Defendant”) arguing that Plaintiff lacks standing to bring this claim. Def.’s MTD, ECF No. 9. Plaintiff filed Plaintiff’s Reply to Defendant’s

Motion to Dismiss. Pl.’s Reply Def.’s MTD (“Pl.’s Resp.”), ECF No. 13. Defendant filed its Reply in Support of its Motion to Dismiss. Def.’s Reply, ECF No. 14. For the following reasons, the Court grants Defendant’s Motion to Dismiss.

BACKGROUND

President Trump issued Proclamation 10886 on January 20, 2025, declaring a national emergency at the United States southern border with Mexico, citing the threat posed by “cartels, criminal gangs, known terrorists, human traffickers, smugglers, unvetted military-age males from foreign adversaries, and illicit narcotics.” Proclamation 10886, 90 Fed. Reg. 8327 (Jan. 20, 2025) (declaring a national emergency at the southern border of the United States). The scope of the national emergency was subsequently expanded on February 1, 2025, to include Mexico, Canada, and the People’s Republic of China (“China”) in response to the claimed failure of those nations to address the flow of illicit drugs into the United States. Exec. Order No. 14193, 90 Fed. Reg. 9113 (Feb. 1, 2025) (imposing duties to address the flow of illicit drugs across our northern border); Exec. Order No. 14194, 90 Fed. Reg. 9117 (Feb. 1, 2025) (imposing duties to address the situation at our southern border); Exec. Order No. 14195, 90 Fed. Reg. 9121 (Feb. 1, 2025) (imposing duties to address the synthetic opioid supply chain in the People’s Republic of China). Asserting authority under the International Emergency

Economic Powers Act (“IEEPA”), 50 U.S.C. § 1701, et seq., and the National Emergencies Act, 59 U.S.C. § 1601, et seq., the President imposed tariffs on goods imported from Mexico, Canada, and China. Exec. Order No. 14193, 90 Fed. Reg. 9113–16; Exec. Order No. 14194, 90 Fed. Reg. 9117–20; Exec. Order No. 14195, 90 Fed. Reg. at 9121–24.

Plaintiff filed his Complaint on February 3, 2025. Compl. Since the Complaint was filed, the tariffs on goods from Canada and Mexico have been paused or amended multiple times. Exec. Order No. 14197, 90 Fed. Reg. 9183 (Feb. 3, 2025) (progress on the situation at our northern border); Exec. Order No. 14198, 90 Fed. Reg. 9185 (Feb. 3, 2025) (progress on the situation at our southern border); Exec. Order No. 14227, 90 Fed. Reg. 11,371 (Mar. 2, 2025) (amendment to duties to address the situation at our southern border); Exec. Order No. 14231, 90 Fed. Reg. 11,785 (Mar. 6, 2025) (amendment to duties to address the flow of illicit drugs across our northern border); Exec. Order No. 14232, 90 Fed. Reg. 11,787 (Mar. 6, 2025) (amendment to duties to address the flow of illicit drugs across our southern border). The President issued Executive Order 14228 on March 3, 2025, increasing the duty rate applicable to China from ten percent to 20 percent. Exec. Order No. 14228, 90 Fed. Reg. 11,463 (Mar. 3, 2025) (further amendment to duties addressing synthetic opioid supply chain in the People’s Republic of China). On April 2, 2025, the President issued Executive Order

14257, which imposed a ten percent duty on all dutiable goods imported into the United States. Exec. Order No. 14257, 90 Fed. Reg. 15,041 (Apr. 2, 2025) (regulating imports with a reciprocal tariff to rectify trade practices that contribute to large and persistent annual United States goods trade deficits). Executive Order 14257 incorporated the tariffs previously imposed on Mexico and Canada and added a country-specific tariff of 34 percent on goods from China. Id. at 15,045– 47, Annex I. Executive Order 14256 was issued on the same day, eliminating de minimis treatment under 19 U.S.C. § 1321(a)(2)(C) for certain products from China. Exec. Order No. 14256, 90 Fed. Reg. 14,899 (Apr. 2, 2025) (further amendment to duties addressing the synthetic opioid supply chain in the People’s Republic of China as applied to low-value imports). Tariff rates applicable to Chinese goods were subsequently increased on April 8 and 9 through executive orders. Exec. Order No. 14259, 90 Fed. Reg. 15,509 (Apr. 8, 2025) (amendment to reciprocal tariffs and updated duties as applied to low-value imports from the People’s Republic of China); Exec. Order No. 14266, 90 Fed. Reg. 15,625 (Apr. 9, 2025) (modifying reciprocal tariff rates to reflect trading partner retaliation and alignment). On May 12, 2025, President Trump issued another executive order that removed the tariffs imposed on China through the April 8 and 9, 2025 executive orders and suspended for 90 days 24 percentage points and retained ten percentage points of the ad valorem duty rate imposed through the April 2, 2025

executive order. Exec. Order No. 14298, 90 Fed. Reg. 21,831 (May 12, 2025) (modifying reciprocal tariff rates to reflect discussions with the People’s Republic of China).

JURISDICTION AND STANDARD OF REVIEW Plaintiff asserts that this Court has jurisdiction pursuant to 28 U.S.C.

§ 1581(i), which Defendant does not dispute. Federal courts must have an independent jurisdictional basis to resolve the matter presented. Badgerow v. Walters, 596 U.S. 1, 4 (2022) (citing Hall Street Assocs., LLC v. Mattel, Inc., 552 U.S. 576, 582 (2008)).

Through Section 1581(i), Congress has granted to the U.S. Court of International Trade “exclusive jurisdiction” over:

any civil action commenced against the United States, its agencies, or its officers, that arises out of any law of the United States providing for—

(A) revenue from imports or tonnage;

(B) tariffs, duties, fees, or other taxes on the importation of merchandise for reasons other than the raising of revenue;

(C) embargoes or other quantitative restrictions on the importation of merchandise for reasons other than the protection of the public health or safety; or (D) administration and enforcement with respect to the matters referred to in subparagraphs (A) through (C) of this paragraph and subsections (a)–(h) of this section.

28 U.S.C. § 1581(i)(1); see also Orleans Int’l, Inc. v. United States, 334 F.3d 1375, 1378 (Fed. Cir. 2003) (concluding that Congress’ grant of exclusive jurisdiction to

the U.S. Court of International Trade over matters described in Section 1581(i) removed from other federal district courts general federal-question jurisdiction over those matters). “Section 1581(i) embodies a ‘residual’ grant of jurisdiction, and may not be invoked when jurisdiction under another subsection of § 1581 is or could have been available, unless the remedy provided under that other subsection would be manifestly inadequate.” Sunpreme, Inc. v. United States, 892 F.3d 1186, 1191 (Fed. Cir. 2018) (citing Fujitsu Gen. Am., Inc. v. United States, 283 F.3d 1364, 1371 (Fed. Cir. 2002)).

Free access — add to your briefcase to read the full text and ask questions with AI

Barnes v. United States, 2025 CIT 65 (cit 2025).

2025 CIT 65 (Barnes v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Totes-Isotoner Corp. v. United States
594 F.3d 1346 (Federal Circuit, 2010)
Fairchild v. Hughes
258 U.S. 126 (Supreme Court, 1922)
Massachusetts v. Mellon
262 U.S. 447 (Supreme Court, 1923)
Baker v. Carr
369 U.S. 186 (Supreme Court, 1962)
Schlesinger v. Reservists Committee to Stop the War
418 U.S. 208 (Supreme Court, 1974)
Warth v. Seldin
422 U.S. 490 (Supreme Court, 1975)
Davis v. Passman
442 U.S. 228 (Supreme Court, 1979)
Regan v. Wald
468 U.S. 222 (Supreme Court, 1984)
Asarco Inc. v. Kadish
490 U.S. 605 (Supreme Court, 1989)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Kokkonen v. Guardian Life Insurance Co. of America
511 U.S. 375 (Supreme Court, 1994)
Raines v. Byrd
521 U.S. 811 (Supreme Court, 1997)
United States v. United States Shoe Corp.
523 U.S. 360 (Supreme Court, 1998)
DaimlerChrysler Corp. v. Cuno
547 U.S. 332 (Supreme Court, 2006)
Hein v. Freedom From Religion Foundation, Inc.
551 U.S. 587 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Hall Street Associates, L. L. C. v. Mattel, Inc.
552 U.S. 576 (Supreme Court, 2008)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)